Boehringer Ingelheim has entered into a global licensing agreement with Immunitas Therapeutics for a preclinical antibody program. This transaction underscores... Read more
Category: Uncategorized
Leading Vietnamese pharmaceutical firms transition to foreign control
The Vietnamese pharmaceutical landscape is experiencing a significant influx of international capital, with nearly all top-tier firms by market capitalization... Read more
Ministry of Health proposes a unified focal point for food safety management
On the afternoon of May 12, 2026, Minister of Health Dao Hong Lan chaired a meeting with relevant ministries and... Read more
HIU completes hospital-university model: President Pham Van Linh appointed as Hospital Director
Hong Bang International University (HIU) has officially announced the appointment of Prof. Dr. Pham Van Linh as the Director of... Read more
Bristol Myers Squibb and Hengrui Pharma forge $15B alliance to accelerate global R&D
Bristol Myers Squibb (BMS) has announced a major collaboration and licensing agreement with China-based Hengrui Pharma. The deal covers 13... Read more
Livzon Group completes acquisition, securing majority control of Imexpharm Pharmaceutical
The Vietnamese pharmaceutical landscape has seen a significant shift in corporate ownership at Imexpharm Pharmaceutical JSC (Ticker: IMP). As of... Read more
Bristol Myers Squibb and Hengrui Pharma enter $15B strategic alliance to leverage China’s R&D speed
Bristol Myers Squibb (BMS) has formed a broad partnership with Hengrui Pharma in a deal potentially worth up to $15.2... Read more
Eli Lilly allocates additional $4.5B to expand Indiana manufacturing footprint
Eli Lilly and Company has announced a further $4.5 billion investment across two of its sites in Lebanon, Indiana. This... Read more
GSK and SBP Group partner to accelerate the launch of Hepatitis B therapy in China
Pharmaceutical giant GSK has entered into an exclusive collaboration with Sino Biopharmaceutical (SBP Group), specifically through its subsidiary Chia Tai... Read more








